« Back
Home /
Gelatins

Gelatins

Item no.	HY-Y1365-50mg
Manufacturer	MedChem Express
CASRN	9000-70-8
Amount	50 mg
Quantity options	100 mg 1 g 500 mg 50 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.0
Citations	[1]Zhaofeng Shi, et al. Biosynthesis of gold nanoparticles by using gelatin as reducing and stabilizing agent under ultrasound irradiation: Application of its catalytic activity and for ameliorating motor recovery after spinal cord injury in the Wistar rat’s model. Inorganic Chemistry Communications. 2024 Sep;167: 112833.\|[2]Yu-He Zhu, et al. Dialdehyde starch cross-linked aminated gelatin sponges with excellent hemostatic performance and biocompatibility. Carbohydrate Polymers. 2024 Oct;342:122326.\|[3]Fu J, et al. Lyophilized Gelatin@non-Woven Scaffold to Promote Spheroids Formation and Enrich Cancer Stem Cell Incidence. Nanomaterials (Basel). 2022 Feb 28;12(5):808. \|[4] Dong L, et al. A pH/enzyme-responsive tumor-specific delivery system for doxorubicin. Biomaterials. 2010 Aug;31(24):6309-16. \|[5]Huang CY, et al. Enhancement of Cell Adhesion, Cell Growth, Wound Healing, and Oxidative Protection by Gelatins Extracted from Extrusion-Pretreated Tilapia (Oreochromis sp.) Fish Scale. Molecules. 2018 Sep 20;23(10):2406.
Smiles	[Gelatins]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Biochemical Assay Reagents
Manufacturer - Targets	Biochemical Assay Reagents
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Product Description	Gelatins is a non-toxic, non carcinogenic, biodegradable, and non irritating natural polymer derived from partial hydrolysis of collagen. Due to its strong liquid absorption and swelling ability, Gelatins has excellent hemostatic properties and can be used as a matrix material for the reduction, growth, and stability of metal nanoparticles. Gelatins can also be used for tumor cell culture and tumor therapy[1][2][3].
Manufacturer - Research Area	Cancer; Metabolic Disease
Solubility	DMSO: 4.55 mg/mL (ultrasonic; warming; heat to 60°C)\|H2O: 50 mg/mL (ultrasonic)
Manufacturer - Pathway	Others
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-Y1365-50mg-safety-datasheet.pdf